| Tue, Feb 9, 2010 | | • | New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen(R), an Experimental Therapeutic
GlobeNewswire (Tue 12:45AM)
| | Fri, Feb 5, 2010 | | • | Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions
GlobeNewswire (Fri, Feb 5)
| | Wed, Feb 3, 2010 | | • | Hemispherx: FDA office says one Ampligen issue addressed
at bizjournals.com (Wed, Feb 3)
| | • | Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response
GlobeNewswire (Wed, Feb 3)
| | Fri, Jan 29, 2010 | | • | Stanford University Publishes New Data on Immuno-potential of Hemispherx's Ampligen(R)
GlobeNewswire (Fri, Jan 29)
| | Mon, Jan 25, 2010 | | • | Biotech Stock Alert for Hemispherx Biopharma Inc. Issued by InvestorSoup
GlobeNewswire (Mon, Jan 25)
| | Fri, Jan 15, 2010 | | • | Biotech Stock Mailbag: Adventrx Pharmaceuticals
at TheStreet.com (Fri, Jan 15)
| | • | Hemispherx Biopharma Provides Grant to IACFS to Assist in the Development of Chronic Fatigue Syndrome (CFS) Clinical Guidelines
GlobeNewswire (Fri, Jan 15)
| | • | Hemispherx submits new Ampligen data to FDA
at bizjournals.com (Fri, Jan 15)
| | • | Hemispherx Biopharma Addresses Ampligen(R) CFS Preclinical Issues
GlobeNewswire (Fri, Jan 15)
| | Fri, Jan 8, 2010 | | • | Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Hemispherx Biopharma, Inc.
Business Wire (Fri, Jan 8)
| | Thu, Jan 7, 2010 | | • | InvestorSoup Initiates Independent Research Coverage for Hemispherx Biopharma Inc.
GlobeNewswire (Thu, Jan 7)
| | Wed, Jan 6, 2010 | | • | Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
PR Newswire (Wed, Jan 6)
| | Wed, Dec 30, 2009 | | • | Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Hemispherx Biopharma, Inc. Investors
Business Wire (Wed, Dec 30)
| | • | Swine Flu Vaccine News Back From the Dead
Indie Research (Wed, Dec 30)
| | Fri, Dec 18, 2009 | | • | Biotech Stock Mailbag: Year in Review
at TheStreet.com (Fri, Dec 18)
| | Thu, Dec 17, 2009 | | • | Hemispherx Biopharma Addresses Ampligen(R) Manufacturing Issues
GlobeNewswire (Thu, Dec 17)
| | Sat, Dec 12, 2009 | | • | Brower Piven Announces the Filing of a Class Action Lawsuit Against Hemispherx Biopharma, Inc. Expanding the Class Period to Include February 18, 2009 Through December 1, 2009, and Encourages Investors Who Have Losses in Excess of $100,000
Marketwire (Sat, Dec 12)
| | Fri, Dec 11, 2009 | | • | Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
PR Newswire (Fri, Dec 11)
| | • | Skymark Research Initiates Independent Research Coverage on Hemispherx Biopharma, Inc.
GlobeNewswire (Fri, Dec 11)
| | Older Headlines | |
| |
|
Headlines
Help
